293 related articles for article (PubMed ID: 35011552)
1. Recent Progress in the Development of Indole-Based Compounds Active against Malaria, Trypanosomiasis and Leishmaniasis.
Pacheco PAF; Santos MMM
Molecules; 2022 Jan; 27(1):. PubMed ID: 35011552
[TBL] [Abstract][Full Text] [Related]
2. Potentials of marine natural products against malaria, leishmaniasis, and trypanosomiasis parasites: a review of recent articles.
Nweze JA; Mbaoji FN; Li YM; Yang LY; Huang SS; Chigor VN; Eze EA; Pan LX; Zhang T; Yang DF
Infect Dis Poverty; 2021 Jan; 10(1):9. PubMed ID: 33482912
[TBL] [Abstract][Full Text] [Related]
3. State-of-the-art Review on the Antiparasitic Activity of Benzimidazolebased Derivatives: Facing Malaria, Leishmaniasis, and Trypanosomiasis.
Francesconi V; Rizzo M; Schenone S; Carbone A; Tonelli M
Curr Med Chem; 2024; 31(15):1955-1982. PubMed ID: 37718524
[TBL] [Abstract][Full Text] [Related]
4. Exploring the Potential of Natural Products as Antiparasitic Agents for Neglected Tropical Diseases.
Orosco D; Mendoza AR; Meléndez CM
Curr Top Med Chem; 2024; 24(2):89-108. PubMed ID: 37842892
[TBL] [Abstract][Full Text] [Related]
5. An Overview of Drug Resistance in Protozoal Diseases.
Capela R; Moreira R; Lopes F
Int J Mol Sci; 2019 Nov; 20(22):. PubMed ID: 31731801
[TBL] [Abstract][Full Text] [Related]
6. An Overview on Target-Based Drug Design against Kinetoplastid Protozoan Infections: Human African Trypanosomiasis, Chagas Disease and Leishmaniases.
Kourbeli V; Chontzopoulou E; Moschovou K; Pavlos D; Mavromoustakos T; Papanastasiou IP
Molecules; 2021 Jul; 26(15):. PubMed ID: 34361781
[TBL] [Abstract][Full Text] [Related]
7. Targeting Trypanothione Reductase, a Key Enzyme in the Redox Trypanosomatid Metabolism, to Develop New Drugs against Leishmaniasis and Trypanosomiases.
Battista T; Colotti G; Ilari A; Fiorillo A
Molecules; 2020 Apr; 25(8):. PubMed ID: 32326257
[TBL] [Abstract][Full Text] [Related]
8. Cysteine proteases as potential targets for anti-trypanosomatid drug discovery.
Judice WAS; Ferraz LS; Lopes RM; Vianna LDS; Siqueira FDS; Di Iorio JF; Dalzoto LAM; Trujilho MNR; Santos TDR; Machado MFM; Rodrigues T
Bioorg Med Chem; 2021 Sep; 46():116365. PubMed ID: 34419821
[TBL] [Abstract][Full Text] [Related]
9. Leishmania donovani, Plasmodium berghei, Trypanosoma rhodesiense: antiprotozoal effects of some amidine types.
Steck EA; Kinnamon KE; Rane DS; Hanson WL
Exp Parasitol; 1981 Dec; 52(3):404-13. PubMed ID: 7032963
[No Abstract] [Full Text] [Related]
10. Alsinol, an arylamino alcohol derivative active against Plasmodium, Babesia, Trypanosoma, and Leishmania: past and new outcomes.
Arias MH; Quiliano M; Bourgeade-Delmas S; Fabing I; Chantal I; Berthier D; Minet C; Eparvier V; Sorres J; Stien D; Galiano S; Aldana I; Valentin A; Garavito G; Deharo E
Parasitol Res; 2020 Oct; 119(10):3503-3515. PubMed ID: 32772176
[TBL] [Abstract][Full Text] [Related]
11. A recent update on new synthetic chiral compounds with antileishmanial activity.
Verboni M; Olivieri D; Lucarini S
Chirality; 2022 Oct; 34(10):1279-1297. PubMed ID: 35947400
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and Evaluation of Biological Activities of Bis(spiropyrazolone)cyclopropanes: A Potential Application against Leishmaniasis.
Barreiro-Costa O; Morales-Noboa G; Rojas-Silva P; Lara-Barba E; Santamaría-Aguirre J; Bailón-Moscoso N; Romero-Benavides JC; Herrera A; Cueva C; Ron-Garrido L; Poveda A; Heredia-Moya J
Molecules; 2021 Aug; 26(16):. PubMed ID: 34443548
[TBL] [Abstract][Full Text] [Related]
13. Recent developments in drug discovery for leishmaniasis and human African trypanosomiasis.
Nagle AS; Khare S; Kumar AB; Supek F; Buchynskyy A; Mathison CJ; Chennamaneni NK; Pendem N; Buckner FS; Gelb MH; Molteni V
Chem Rev; 2014 Nov; 114(22):11305-47. PubMed ID: 25365529
[No Abstract] [Full Text] [Related]
14. Natural Occurrence in Venomous Arthropods of Antimicrobial Peptides Active against Protozoan Parasites.
Sabiá Júnior EF; Menezes LFS; de Araújo IFS; Schwartz EF
Toxins (Basel); 2019 Sep; 11(10):. PubMed ID: 31557900
[TBL] [Abstract][Full Text] [Related]
15. Anti-leishmanial and anti-trypanosomal natural products from endophytes.
Hzounda Fokou JB; Dize D; Etame Loe GM; Nko'o MHJ; Ngene JP; Ngoule CC; Boyom FF
Parasitol Res; 2021 Mar; 120(3):785-796. PubMed ID: 33409640
[TBL] [Abstract][Full Text] [Related]
16. Potential therapeutic use of herbal extracts in trypanosomiasis.
Teixeira TL; Teixeira SC; da Silva CV; de Souza MA
Pathog Glob Health; 2014 Jan; 108(1):30-6. PubMed ID: 24548158
[TBL] [Abstract][Full Text] [Related]
17. Protozoan persister-like cells and drug treatment failure.
Barrett MP; Kyle DE; Sibley LD; Radke JB; Tarleton RL
Nat Rev Microbiol; 2019 Oct; 17(10):607-620. PubMed ID: 31444481
[TBL] [Abstract][Full Text] [Related]
18. Parasitic sirtuin 2 as an opportunity in drug discovery.
Gomes RA; Fornari E; Silva Rocha AC; Tripodi GL; Silva Emery FD; Goulart Trossini GH
Future Med Chem; 2021 Aug; 13(16):1397-1409. PubMed ID: 34189957
[TBL] [Abstract][Full Text] [Related]
19. Advancement in leishmaniasis diagnosis and therapeutics: An update.
Kumari D; Perveen S; Sharma R; Singh K
Eur J Pharmacol; 2021 Nov; 910():174436. PubMed ID: 34428435
[TBL] [Abstract][Full Text] [Related]
20. Screening Marine Natural Products for New Drug Leads against Trypanosomatids and Malaria.
Álvarez-Bardón M; Pérez-Pertejo Y; Ordóñez C; Sepúlveda-Crespo D; Carballeira NM; Tekwani BL; Murugesan S; Martinez-Valladares M; García-Estrada C; Reguera RM; Balaña-Fouce R
Mar Drugs; 2020 Mar; 18(4):. PubMed ID: 32244488
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
